T1	Outcomes 34 74	senescent T-lymphocyte subsets in blood.
T2	Outcomes 269 329	phenotypic characteristics of T-lymphocyte subsets in blood.
T3	Outcomes 806 975	increased the mobilization of CD3, CD4, CD8, or CD8(bright) lymphocytes expressing activated (CD11a) or senescent (KLRG1) molecules into the peripheral blood compartment
T4	Outcomes 998 1050	up-regulated co-stimulatory molecule CD28 expression
T5	Outcomes 1074 1140	depressed KLRG1 level on CD3, CD4, CD8, or CD8(bright) lymphocytes
T6	Outcomes 1206 1272	increased interferon-γ (IFN-γ) level and unchanged interleukin-4
T7	Outcomes 1288 1348	as, decreased myeloperoxidase (MPO) and interleukin-6 levels
T8	Outcomes 1407 1498	exercise-induced mobilizations of various T-lymphocyte subsets and productions of cytokines
T9	Outcomes 1609 1689	intervention reduced senescent T-lymphocyte subsets with increasing IFN-γ level
T10	Outcomes 1720 1791	accompanied by depressed oxidative stress and pro-inflammatory cytokine
T11	Outcomes 1871 1897	regimen to minimize immune
T12	Outcomes 1910 1935	by retarding T-lymphocyte
